Cantor Fitzgerald Maintains Overweight on Disc Medicine, Lowers Price Target to $125
Disc Medicine, Inc. +0.48%
Disc Medicine, Inc. IRON | 70.81 | +0.48% |
Cantor Fitzgerald analyst Kristen Kluska maintains Disc Medicine (NASDAQ:
IRON) with a Overweight and lowers the price target from $153 to $125.
